药学研究
藥學研究
약학연구
JOURNAL OF PHARMACEUTICAL RESEARCH
2015年
1期
45-46
,共2页
临床药师%结肠癌%伊立替康%药学监护
臨床藥師%結腸癌%伊立替康%藥學鑑護
림상약사%결장암%이립체강%약학감호
Clinical pharmacist%Colon cancer%Irinotecan%Pharmaceutical care
1例52岁女性患者,结肠癌术后1年余,发现双肺转移瘤1 d入院。入院后给予FOLFIRI方案化疗,临床药师对患者进行用药注意事项教育,对药物不良反应进行监测,指导护士以正确顺序给药,建议临床医师加用阿托品降低伊立替康的不良反应,患者最终顺利完成本周期治疗。
1例52歲女性患者,結腸癌術後1年餘,髮現雙肺轉移瘤1 d入院。入院後給予FOLFIRI方案化療,臨床藥師對患者進行用藥註意事項教育,對藥物不良反應進行鑑測,指導護士以正確順序給藥,建議臨床醫師加用阿託品降低伊立替康的不良反應,患者最終順利完成本週期治療。
1례52세녀성환자,결장암술후1년여,발현쌍폐전이류1 d입원。입원후급여FOLFIRI방안화료,림상약사대환자진행용약주의사항교육,대약물불량반응진행감측,지도호사이정학순서급약,건의림상의사가용아탁품강저이립체강적불량반응,환자최종순리완성본주기치료。
A 52—year—old female patient,more than 1 years after resection of colon cancer,found the double lung me-tastases 1 days of admission. After adminssion,she received the FOLFIRI therapy,the clinical pharmacist guided the patient correct medication method of the drugs,monitored the adverse reactions,guided the nurses in the correct sequence of admin-istration,suggested that clinicians with atropine reduced adverse reactions of irinotecan. At last,the cycle of therapy for the patient was successfully finished.